Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 18/20 | 0.34 |
| ▸ | ITGA2B | P08514 | 18/20 | 0.34 |
| ▸ | F2 | P00734 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7372624 | 0.86 | F2 (0.32) | ITGB3ITGA2BF2 | |
| SCHEMBL7847593 | 0.84 | ITGB3 (0.44) | ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL9093493 | 0.79 | ITGB3 (0.35) | ITGB3ITGA2BF2 | |
| SCHEMBL7375675 | 0.78 | ITGB3 (0.43) | ITGB3ITGA2B | |
| SCHEMBL9093436 | 0.75 | ITGB3 (0.47) | ITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL9093882 | 0.74 | ITGB3 (0.47) | ITGB3ITGA2B | |
| SCHEMBL7367239 | 0.73 | ITGB3 (0.39) | ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL9095818 | 0.71 | ITGB3 (0.45) | ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL7790851 | 0.71 | ITGB3 (0.45) | ITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL7790802 | 0.71 | ITGB3 (0.45) | ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996038426-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-12-05 | — | — | WO | disclosed |
| WO-1995014683-A1 | NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-06-01 | — | — | WO | disclosed |